Vistin Pharma ASA Statistics

Total Valuation

Vistin Pharma ASA has a market cap or net worth of GBP 73.12 million. The enterprise value is 73.30 million.

Market Cap	73.12M
Enterprise Value	73.30M

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	Nov 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	21.17M

Valuation Ratios

The trailing PE ratio is 16.82.

PE Ratio	16.82
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	3.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.02, with an EV/FCF ratio of 18.55.

EV / Earnings	16.86
EV / Sales	2.39
EV / EBITDA	10.02
EV / EBIT	12.31
EV / FCF	18.55

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.03.

Current Ratio	2.13
Quick Ratio	1.06
Debt / Equity	0.03
Debt / EBITDA	0.08
Debt / FCF	0.15
Interest Coverage	11.47

Financial Efficiency

Return on equity (ROE) is 20.06% and return on invested capital (ROIC) is 16.57%.

Return on Equity (ROE)	20.06%
Return on Assets (ROA)	13.34%
Return on Capital (ROIC)	16.57%
Revenue Per Employee	402,946
Profits Per Employee	57,977
Employee Count	77
Asset Turnover	1.10
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.18% in the last 52 weeks. The beta is 1.03, so Vistin Pharma ASA's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-4.18%
50-Day Moving Average	22.25
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.66
Average Volume (20 Days)	1,055

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vistin Pharma ASA had revenue of GBP 30.22 million and earned 4.35 million in profits. Earnings per share was 0.10.

Revenue	30.22M
Gross Profit	19.67M
Operating Income	5.86M
Pretax Income	5.58M
Net Income	4.35M
EBITDA	7.13M
EBIT	5.86M
Earnings Per Share (EPS)	0.10

Full Income Statement

Balance Sheet

The company has 398,979 in cash and 576,894 in debt, giving a net cash position of -177,915.

Cash & Cash Equivalents	398,979
Total Debt	576,894
Net Cash	-177,915
Net Cash Per Share	n/a
Equity (Book Value)	22.02M
Book Value Per Share	0.50
Working Capital	5.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.08 million and capital expenditures -3.12 million, giving a free cash flow of 3.95 million.

Operating Cash Flow	7.08M
Capital Expenditures	-3.12M
Free Cash Flow	3.95M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.08%, with operating and profit margins of 19.38% and 14.39%.

Gross Margin	65.08%
Operating Margin	19.38%
Pretax Margin	18.46%
Profit Margin	14.39%
EBITDA Margin	23.58%
EBIT Margin	19.38%
FCF Margin	13.08%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of n/a.

Dividend Per Share	0.07
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	90.30%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.95%
FCF Yield	5.40%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Vistin Pharma ASA has an Altman Z-Score of 10.36.

Altman Z-Score	10.36
Piotroski F-Score	n/a